Pioneering research, novel molecule discovery & development
Setting the standards through collaborative development, applied research and superlative in-house experience in the characterization and modification of natural products for use in rare neurological disorders.
Our Company
A spin-out of Agroceutical Products Ltd. acclaimed lab, Odyssey Neuroscience is a UK-based Biopharmaceutical Company.
Our purpose is to develop novel tryptaminergic therapies for a range of debilitating diseases affecting both the central nervous system (CNS) and the peripheral nervous system (PNS).
These diseases significantly reduce the quality of life in individuals afflicted by them reducing their ability to work and can incur large economic costs.
Our entry into the headache arena will focus on Trigeminal Autonomic Cephalgias (TACs) and migraines and is backed by a long history of developing natural product therapeutics and a deep understanding of the power of natural scaffolds.
We are focused to further the science of tryptaminergic compounds from nature’s medicine cabinit
Key Functions
Preclinical Development
Advances drug candidates through preclinical development by validating targets, optimising leads, and generating proof-of-concept data.
Delivers IND-enabling studies, including safety, pharmacology, and formulation work, to prepare programs for clinical testing.
Clinical Development
Progressing therapies through clinical development by designing and running trials to evaluate safety, dosing, and efficacy.
Generating the clinical evidence needed to guide regulatory strategy and support approval decisions.
